ESR1 and breast cancer: In addition, an earlier study has shown that tamoxifen acts and an MDR-reversing drug in drug resistant P388/ADR murine leukemia cells [23], and can induce apoptosis, in both estrogen receptor-α positive and –negative breast cancer cells, by increasing intracellular ROS levels [24].